Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

Clinical trial NCT05051956 · UNKNOWN

Trial details

NCT number: NCT05051956
Sponsor: Namik Kemal University
Status: UNKNOWN
Study type: OBSERVATIONAL

Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors

Start date: 2021-10-01
Primary completion: 2021-12-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.